Robert Z Orlowski

Robert Z Orlowski

M D Anderson Cancer Center University of Texas - Houston / United States
Others
AD Scientific Index ID: 1406934
MD Anderson Cancer Center
person_outline Robert Z Orlowski's MOST POPULAR ARTICLES
1-) A phase 2 study of bortezomib in relapsed, refractory myelomaPG Richardson, B Barlogie, J Berenson, S Singhal, S Jagannath, D Irwin, ...New England Journal of Medicine 348 (26), 2609-2617, 200333132003
2-) International Myeloma Working Group consensus criteria for response and minimal residual disease assessment in multiple myelomaS Kumar, B Paiva, KC Anderson, B Durie, O Landgren, P Moreau, ...The lancet oncology 17 (8), e328-e346, 201617992016
3-) Revised international staging system for multiple myeloma: a report from International Myeloma Working GroupA Palumbo, H Avet-Loiseau, S Oliva, HM Lokhorst, H Goldschmidt, ...Journal of clinical oncology 33 (26), 2863, 201516492015
4-) Daratumumab, lenalidomide, and dexamethasone for multiple myelomaMA Dimopoulos, A Oriol, H Nahi, J San-Miguel, NJ Bahlis, SZ Usmani, ...New England Journal of Medicine 375 (14), 1319-1331, 201616792016
5-) Elotuzumab therapy for relapsed or refractory multiple myelomaS Lonial, M Dimopoulos, A Palumbo, D White, S Grosicki, I Spicka, ...New England Journal of Medicine 373 (7), 621-631, 201515852015